Decision Support · Side-by-side

Deep Genomics vs Recursion OS. Side by side.

Compare pricing, strengths, and use cases so it is easier to pick the right fit.

Browse alternatives Browse workflows

Change tools

Comparison Ready

Deep Genomics

Recursion OS

Best overall

Neither Deep Genomics nor Recursion OS is for everyday users—both are enterprise-grade drug discovery platforms. Deep Genomics wins for specialized RNA-therapeutics and non-coding variant analysis, while Recursion OS is broader for phenotypic screening and target ID. The single biggest difference: Deep Genomics focuses on antisense oligonucleotide design, whereas Recursion OS uses cell imaging and multi-omics for drug discovery.

Deep Genomics

#4200 of 3,826 Web

Recursion OS

#3693 of 3,826 Web

Scores at a glance

Deep GenomicsRecursion OSPractical Versatility

Onboarding Ease

Ecosystem Fit

Market Value

Choose Deep Genomics if

You are a pharmaceutical company developing RNA-targeted therapies for rare genetic diseases
Your research focuses on non-coding variants and splicing defects
You have a team of bioinformaticians and access to proprietary genomic datasets
You need an end-to-end platform from variant prediction to IND filing

Choose Recursion OS if

You are a drug discovery team using phenotypic cell imaging to find new drug candidates
You want to combine genomic, proteomic, and chemical data in one platform
You need predictive models and clinical trial simulations before wet-lab experiments
You have a budget for enterprise software and a team to manage complex data integration

Key differences

Deep Genomics specializes in RNA therapeutics and non-coding variants; Recursion OS uses cell imaging and multi-omics for broader drug discovery.
Deep Genomics has a 10-step onboarding with wet-lab validation; Recursion OS has an 8-step process but still requires expert training.
Neither has a mobile app or public API, making both unsuitable for everyday users.
Deep Genomics is more focused on antisense oligonucleotide design; Recursion OS covers target ID, compound screening, and clinical trial simulation.
Both have hidden enterprise pricing, but Recursion OS is slightly more versatile due to broader data integration.
Deep Genomics has proven partnerships with Tier-1 pharma; Recursion OS is known for its large-scale phenotypic screening platform.

Facts side by side

	Deep Genomics	Recursion OS
Free plan
Mobile app
API access

Deep Genomics: strengths & weaknesses

Best-in-class prediction for non-coding DNA variants
End-to-end ASO drug design pipeline
Proven partnerships with top pharmaceutical companies
No mobile app or public API
Requires specialized genomic data (FASTA, VCF, BAM)
Pricing is hidden and enterprise-only
Steep 10-step onboarding with wet-lab validation

Recursion OS: strengths & weaknesses

Integrates cell imaging, genomics, proteomics, and chemical data
Accelerates target identification and compound screening
Offers clinical trial simulation capabilities
No mobile app or public API
Complex interface with steep learning curve
High cost and no transparent pricing
Requires large-scale biological datasets to get value

Common questions

Can I use Deep Genomics or Recursion OS on my phone?

No. Neither tool has a mobile app or mobile-friendly interface. They are enterprise platforms designed for desktop use by specialized research teams.

Are these tools free or affordable for a small startup?

No. Both have hidden pricing and are enterprise-only. Expect six-figure annual contracts. They are not designed for individuals or small labs without significant funding.

Which is better for a non-technical person?

Neither. Both require deep expertise in genomics, bioinformatics, or drug discovery. If you are a non-technical person, look at simpler AI tools like ChatGPT or Perplexity for general tasks.

What is the main difference between Deep Genomics and Recursion OS?

Deep Genomics focuses on RNA splicing prediction and antisense oligonucleotide design. Recursion OS uses cell imaging and multi-omics for target identification and compound screening. Choose based on your therapeutic approach.

Do these tools integrate with common lab software?

No public integrations are listed for either tool. They likely work with proprietary data formats (FASTA, VCF, BAM, cell images) but do not offer plug-and-play connections to standard lab tools.

Deep Genomics and Recursion OS are powerful but inaccessible to everyday users—both are enterprise-only, lack mobile apps, and require specialized expertise, so skip them unless you're a biotech professional.

If you are an everyday user looking for AI tools, neither Deep Genomics nor Recursion OS is for you—they are enterprise platforms for professional drug discovery teams. For general AI assistance, try ChatGPT or Claude. If you work in pharma, Recursion OS offers broader capabilities, while Deep Genomics is unmatched for RNA therapeutics.

Visit Deep Genomics Visit Recursion OS

Detail pages: Deep Genomics · Recursion OS

Deep Genomics

Recursion OS

Free plan

Mobile app

API access